BlossomHill Therapeutics, Inc., 2025-12-10
An SEC Form D private-offering notice from San Diego, CA, a $84,152,909 filer-stated offering target in Biotech. Filed 2025-12-10. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage biotech developing small molecule cancer therapies, including a macrocyclic OMNI-EGFR inhibitor for non small cell lung cancer.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Bobyard, Inc., 2025-12-10, $35.3M, Cupertino, CA
- Liberation Bioindustries, Inc., 2025-12-10, $101.7M, New York, NY
- fal - Features & Labels, Inc., 2025-12-10, $140.5M, San Francisco, CA
- Invea Therapeutics, Inc, 2025-12-10, $120K, Guilford, CT
- ConductorOne, Inc., 2025-12-10, $65M, San Francisco, CA
- Verrica Pharmaceuticals Inc., 2025-12-10, $50M, West Chester, PA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.